Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH

HAMBURG, Germany – May 11th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise''), which serves the medical and CBD cannabis market in Germany and CannaCare Health…

Continue ReadingGreenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH

Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors 

HAMBURG, Germany – April 5th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise”), which serves the medical and CBD cannabis market in Germany, and CannaCare Health…

Continue ReadingGreenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors 

Greenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

HAMBURG, Germany, and PERTH, Australia – January 18th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) a distributor of medical and CBD wellness cannabis products…

Continue ReadingGreenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

Greenrise Global’s Medical Cannabis Subsidiary, ​​AMP Alternative Medical Products GmbH Announces the Beginning of Dronabinol Sales in Germany

HAMBURG and BENSHEIM, Germany – January 12th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”), a distributor of medical and CBD wellness cannabis products in…

Continue ReadingGreenrise Global’s Medical Cannabis Subsidiary, ​​AMP Alternative Medical Products GmbH Announces the Beginning of Dronabinol Sales in Germany

Greenrise Global’s Supports Germany’s Approach 
to Cannabis Legalization for Adult Use

BERLIN, ERFURT, Germany – November 25th, 2021, Greenrise Global Brands Inc. (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) would like to comment on…

Continue ReadingGreenrise Global’s Supports Germany’s Approach 
to Cannabis Legalization for Adult Use

Greenrise Global Launches Herbify CBD Wellness Brand in Germany

BERLIN, HAMBURG, Germany – November 23rd, 2021, Greenrise Global Brands Inc.’s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX), (“Greenrise Global”), announces the launch of its…

Continue ReadingGreenrise Global Launches Herbify CBD Wellness Brand in Germany

Greenrise Global Announces Non-Brokered Placement Offering of Units

BERLIN, Germany – November 22nd, 2021, Greenrise Global Brands Inc.’s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX), (“Greenrise Global”), announces it intend to raise up…

Continue ReadingGreenrise Global Announces Non-Brokered Placement Offering of Units